All (n = 176, 100%) | MV > 24 h (n = 27, 15.3%) | MV < 24 h (n = 149, 84.7%) | p value | ||
---|---|---|---|---|---|
Donor and intraoperative data | |||||
Donor type | |||||
Brain death | 68.20% | 70.37% | 67.90% | 0.967 | |
Cardiac death | 31.80% | 29.63% | 32.21% | ||
Donor age (years)c | 59.00 (18.00–84.00) | 58.00 (25.00–84.00) | 60.00 (18.00–78.00) | 0.89 | |
Length of surgery (min)b | 390.00 (303.00–1436.00) | 426.00 (325.00–1455.00) | 380.00 (299.00–1430.00) | 0.398 | |
CIT (min)b | 373.00 (284.00–445.00) | 400.00 (359.00–467.00) | 356.00 (278.00–430.00) | 0.014 | |
WIT (min)b | 36.00 (26.00–50.00) | 35.00 (28.50–45.00) | 36.00 (26.00–50.00) | 0.738 | |
Postreperfusion syndrome | 46.60% | 74.07% | 41.61% | 0.004 | |
Transfusion During LT | |||||
RBC (units)b | 2.00 (0.00–4.00) | 3.00 (1.00–5.00) | 1.00 (0.00–3.00) | 0.001 | |
RBC infusions | 0.001 | ||||
0 units | 33.50% | 7.41% | 38.26% | ||
1–6 units | 57.40% | 70.37% | 55.03% | ||
> 6 units | 9.09% | 22.22% | 6.71% | ||
Fresh frozen plasma | 12.50% | 29.63% | 9.40% | 0.008 | |
Apheresis platelets | 13.64% | 29.63% | 10.74% | 0.015 | |
Tranexamic acid | 39.20% | 62.96% | 33.56% | 0.007 | |
Crystalloids (ml)b | 2280 (1228–3424) | 2200 (1275–35,072) | 2280 (1238–3200) | 0.608 | |
Albuminb | 67.43% | 88.89% | 63.51% | 0.018 | |
Transfusion during and 24 h after LT | |||||
RBC (units) | 2.50 (0.00–5.00) | 4.00 (2.00–7.00) | 2.00 (0.00–4.00) | 0.001 | |
RBC infusions | 0.001 | ||||
0 units | 26.10% | 3.70% | 30.20% | ||
1–6 units | 55.70% | 37.04% | 95.06% | ||
> 6 units | 18.20% | 59.26% | 10.74% | ||
Fluid therapya (ml)b | 5234 (4153–7184) | 6550 (4860–9055) | 4962 (3951–6833) | 0.004 |